Zacks Research Has Weak Forecast for Integer FY2025 Earnings

Integer Holdings Co. (NYSE:ITGR) – Equities research analysts at Zacks Research cut their FY2025 earnings per share (EPS) estimates for Integer in a research report issued to clients and investors on Tuesday, October 22nd. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will earn $6.03 per share for the year, down from their prior estimate of $6.04. The consensus estimate for Integer’s current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Integer’s Q1 2026 earnings at $1.64 EPS, Q3 2026 earnings at $1.66 EPS and FY2026 earnings at $6.68 EPS.

Several other equities research analysts have also recently weighed in on ITGR. Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. KeyCorp upped their target price on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Truist Financial lifted their price target on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a report on Monday, October 14th. Benchmark upped their price objective on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday. Finally, Citigroup lifted their target price on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Integer currently has a consensus rating of “Moderate Buy” and an average target price of $140.14.

Integer Stock Performance

Integer stock opened at $125.58 on Wednesday. Integer has a 1-year low of $69.40 and a 1-year high of $133.53. The firm has a market cap of $4.21 billion, a P/E ratio of 43.45, a P/E/G ratio of 1.86 and a beta of 1.08. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average of $127.19 and a 200-day moving average of $120.82.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $436.20 million during the quarter, compared to analysts’ expectations of $437.00 million. During the same quarter in the prior year, the company posted $1.14 EPS. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.00% of the stock is owned by corporate insiders.

Institutional Trading of Integer

Several institutional investors have recently bought and sold shares of ITGR. GSA Capital Partners LLP bought a new position in shares of Integer during the first quarter valued at $786,000. Blue Trust Inc. lifted its stake in Integer by 460.4% during the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock valued at $658,000 after acquiring an additional 4,636 shares during the period. UniSuper Management Pty Ltd bought a new position in Integer during the 1st quarter valued at about $976,000. Moloney Securities Asset Management LLC purchased a new stake in shares of Integer during the 1st quarter valued at about $927,000. Finally, Earnest Partners LLC grew its stake in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after acquiring an additional 37,340 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.